| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $3.7M | +142.9% |
| SG&A Expense | $6.9M | +44.2% |
| Income Tax | $0 | — |
| Net Income | -$10.2M | -62.4% |
| EPS (Basic) | -$0.39 | -39.3% |
| EPS (Diluted) | -$0.39 | -39.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Current Assets | $29.3M | +309.9% |
| Total Assets | $35.1M | +385.2% |
| Current Liabilities | $1.8M | +717.0% |
| Total Liabilities | $3.5M | +1450.5% |
| Stockholders' Equity | $31.6M | +1473.6% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | -318.8% |
| Capital Expenditures | $1.7M | — |
| Investing Cash Flow | -$3.7M | — |
| Financing Cash Flow | $33.7M | +288.0% |
| Free Cash Flow | -$10.2M | — |